US Patent Issued to BIOGEN MA on June 3 for "Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,679, issued on June 3, was assigned to BIOGEN MA INC. (Cambridge, Mass.).

"Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors" was invented by Nathan Genung (Charlestown, Mass.), Kevin M. Guckian (Northborough, Mass.), Jeffrey Vessels (Marlborough, Mass.), Lei Zhang (Westford, Mass.), Ryan Gianatassio (Everett, Mass.), Edward Yin Shiang Lin (Ashland, Mass.) and Zhili Xin (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds represented by formula (I), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the s...